Live from the NIH registry
Studies recruiting near Hartford right now
Top 25 of 438 recruiting studies, sorted by proximity — each links to its official registry page
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Hartford Hospital (site 210) — Hartford, Connecticut (0.2 mi)
· Sponsor: VM Oncology, LLC
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Collagen Matrix
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
Anterior Cruciate Ligament Reconstruction
N/A
Interventional 40 participants sought
University of Connecticut — Storrs, Connecticut (22.5 mi)
· Sponsor: University of Connecticut
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Alcohol Use Disorder, Cannabis Use Disorder
N/A
Interventional 294 participants sought
UConn Health — Farmington, Connecticut (8.3 mi)
· Sponsor: Massachusetts General Hospital
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Medical Research Center of Connecticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Eli Lilly and Company
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (0.2 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Starling Physicians — Hartford, Connecticut (0.2 mi)
· Sponsor: Pfizer
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (23.7 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Giselle Sholler
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Hartford HealthCare Cancer Institute — Hartford, Connecticut (0.2 mi)
· Sponsor: Kura Oncology, Inc.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Smilow Cancer Hospital at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: Pfizer
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (0.2 mi)
· Sponsor: Janssen Research & Development, LLC
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Elixia SISU BHR - Sprinfield — Springfield, Massachusetts (23.7 mi)
· Sponsor: Ardelyx
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
Advanced Malignancies, Advanced Cancer
Phase 1
Interventional 120 participants sought
Smilow Cancer Hospital - North Haven — North Haven, Connecticut (27.5 mi)
· Sponsor: Pfizer
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
Gastroenterolgy Center of Conneticut — Hamden, Connecticut (27.9 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Connecticut Children's Medical Center — Farmington, Connecticut (8.3 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Hartford Hospital — Hartford, Connecticut (0.2 mi)
· Sponsor: NRG Oncology
Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery
Obesity
N/A
Interventional 164 participants sought
Hartford HealthCare — Hartford, Connecticut (0.2 mi)
· Sponsor: Hartford Hospital
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (22.5 mi)
· Sponsor: University of Connecticut
Effects of Hard Gum Chewing on Facial Soft Tissue Morphology
Face
N/A
Interventional 20 participants sought
UConn Health — Farmington, Connecticut (8.3 mi)
· Sponsor: UConn Health
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (0.2 mi)
· Sponsor: SWOG Cancer Research Network
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
Hartford Healthcare — Hartford, Connecticut (0.2 mi)
· Sponsor: Parkinson's Foundation